Brent A. Neuschwander–Tetri  Gastroenterology 

Slides:



Advertisements
Similar presentations
Ashutosh Gupta, Bashar M. Attar, Vikram Kotwal
Advertisements

Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Obesity Heats Up Adipose Tissue Lymphocytes
SMAD About Hepatitis C Virus Cell Entry and Liver Disease
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Vasoconstrictor Therapy for the Hepatorenal Syndrome
Christoph Lübbert, Babett Holler  Gastroenterology 
Genetics and Genomics in the Practice of Medicine
Effectiveness of Hepatitis B Treatment in Clinical Practice
Volume 153, Issue 4, Pages (October 2017)
Is HCV Infection a Neurologic Disorder?
Outcomes Among Living Liver Donors
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection  Tobias Boettler, Robert Thimme  Gastroenterology 
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 132, Issue 2, Pages (February 2007)
Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
Volume 154, Issue 5, Pages (April 2018)
Volume 148, Issue 4, Pages (April 2015)
Volume 134, Issue 5, Pages (May 2008)
Covering the Cover Gastroenterology
Volume 155, Issue 4, Pages (October 2018)
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Volume 154, Issue 4, Pages (March 2018)
TLL1 rs Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C  Miya John, Mayada Metwally  Gastroenterology 
Volume 155, Issue 5, Pages e2 (November 2018)
Jean-Michel Pawlotsky  Gastroenterology 
Liver Sinusoidal Endothelial Cells: An Antiviral “Defendothelium”
Volume 156, Issue 3, Pages (February 2019)
Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H
A. Sidney Barritt, Michael W. Fried  Gastroenterology 
Volume 142, Issue 6, Pages e3 (May 2012)
Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection  Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco.
Impact of New Hepatitis C Treatments in Different Regions of the World
Ashutosh Gupta, Bashar M. Attar, Vikram Kotwal
Volume 142, Issue 6, Pages (May 2012)
Laura Rotundo, Sushil Ahlawat  Gastroenterology 
Treatment of Clostridium difficile-Associated Disease
Rafael Esteban, Maria Buti  Gastroenterology 
Genetic Testing for Hereditary Colorectal Cancer: Challenges in Identifying, Counseling, and Managing High-Risk Patients  Elena M. Stoffel, Anu Chittenden 
Volume 150, Issue 5, Pages (May 2016)
Melena and Hyperammonemic Seizures in a Turner Syndrome Patient
Brendan Campbell, Benny Liu, Taft Bhuket, Robert J. Wong 
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Will There Be a Vaccine to Protect Against the Hepatitis C Virus?
Patient-Reported Outcomes of Cirrhosis
Volume 148, Issue 3, Pages (March 2015)
Immune Quiescence and Hepatitis B Virus: Tolerance Has Its Limits
Genetic Factors and Hepatitis C Virus Infection
Volume 149, Issue 6, Pages (November 2015)
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C  Gowtham A. Rao, Prashant K. Pandya  Gastroenterology 
The Dawning of a New Editorial Board for Gastroenterology
Alessio Aghemo, Maria Francesca Donato  Gastroenterology 
Volume 139, Issue 1, Pages (July 2010)
Volume 125, Issue 6, Pages (December 2003)
Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects  Kevin M. Korenblat, Elisa.
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
Electronic Clinical Challenges and Images in GI
Volume 148, Issue 4, Pages (April 2015)
Volume 156, Issue 3, Pages (February 2019)
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 138, Issue 6, Pages (May 2010)
Volume 1, Issue 1, Pages 9-14 (January 2005)
Controversies in Liver Transplantation for Hepatitis C
Volume 156, Issue 4, Pages (March 2019)
Volume 135, Issue 6, Pages (December 2008)
Covering the Cover Gastroenterology
Presentation transcript:

Hepatitis C Virus-Induced Insulin Resistance: Not All Genotypes Are the Same  Brent A. Neuschwander–Tetri  Gastroenterology  Volume 134, Issue 2, Pages 619-622 (February 2008) DOI: 10.1053/j.gastro.2007.12.041 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Insulin resistance (IR) has 4 major causes: genetic predisposition, aging, obesity (especially centripetal obesity), and a sedentary lifestyle. There are also genetic factors that predispose to obesity and possibly impaired muscle function, which could promote a sedentary lifestyle. The paper by Moucari et al6 and earlier data place HCV, especially genotypes 1 and 4, on the left-hand causative side of the diagram. Although there are mechanistic explanations why HCV-induced insulin resistance occurs at the cellular level, it is possible that the effect of HCV infection might be more indirect by promoting fatigue and a sedentary lifestyle in some patients. The consequences of insulin resistance are many and include NAFLD. Altered humoral responses to HCV infection caused by insulin resistance or the associated hyperinsulinemia may also impair the ability to clear the virus. Note that commonly used criteria for the metabolic syndrome include both a causative factor (centripetal obesity) and consequences of insulin resistance (hypertension, dyslipidemia, impaired fasting glucose) and thus the metabolic syndrome as it is currently conceived cannot be viewed as a consequence of insulin resistance. Gastroenterology 2008 134, 619-622DOI: (10.1053/j.gastro.2007.12.041) Copyright © 2008 AGA Institute Terms and Conditions